Winton Group LTD Vbi Vaccines Inc Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$2.21 - $3.22 $22,354 - $32,570	-10,115 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$2.8 - $3.72 $28,322 - $37,627	10,115 New	10,115 $31,000
Q1 2020 May 11, 2020	SELL	$0.73 - $1.91 $133,887 - $350,309	-183,408 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.48 - $1.38 $24,113 - $69,327	50,237 Added 37.72%	183,408 $253,000
Q3 2019 Nov 08, 2019	BUY	$0.47 - $1.05 $62,590 - $139,829	133,171 New	133,171 $63,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.